Company Overview of Idenix Pharmaceuticals Inc.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the discovery and development of drugs for the treatment of human viral diseases in the United States and France. Its primary research and development focus is on the treatment of patients with hepatitis C virus (HCV). The company’s HCV discovery program focuses on nucleoside/nucleotide polymerase inhibitors, NS5A inhibitors, protease inhibitors, and non-nucleoside polymerase inhibitors. It is also developing non-nucleoside reverse transcriptase inhibitors for the treatment of human immunodeficiency (HIV) virus type-1 and acquired immune deficiency syndrome (AIDS); and products and drug candidates for the treatment of p...
320 Bent Street
Cambridge, MA 02141
Founded in 1998
Key Executives for Idenix Pharmaceuticals Inc.
Chief Medical Officer and Executive Vice President of Clinical Development
Chief Scientific Officer and Executive Vice President
Senior Vice President of Human Resources
Compensation as of Fiscal Year 2014.
Idenix Pharmaceuticals Inc. Key Developments
Idenix Pharmaceuticals Inc.(NasdaqGM:IDIX) dropped from Russell 2000 Index
Aug 7 14
Idenix Pharmaceuticals Inc. will be removed from the Russell 2000 Index.
Idenix Pharmaceuticals Inc.(NasdaqGM:IDIX) dropped from Russell 3000 Index
Aug 7 14
Idenix Pharmaceuticals Inc. will be removed from the Russell 3000 Index.
Idenix Pharmaceuticals Inc. Announces Resignation of Directors
Aug 5 14
Idenix Pharmaceuticals Inc. announced that in connection with the Merger and as contemplated by the Merger Agreement, each of Ronald C. Renaud, Jr., Wayne T. Hockmeyer, Thomas R. Hodgson, Tamar D. Howson, Denise Pollard-Knight, Charles A. Rowland, Jr. and Michael Wyzga tendered their respective resignations as directors from the company's board of directors and from all committees of the Board on which such directors served, effective as of the effective time of the Merger.
Similar Private Companies By Industry
Recent Private Companies Transactions
June 9, 2014
January 27, 2014
Most Searched Private Companies
Sponsored Financial Commentaries